Indications
Yselty is indicated in adult women of reproductive age for: - treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1).
Composition
- Active substance
- linzagolix choline
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Yselty
- Active substance
- linzagolix choline
- ATC code
- H01CC04
- Therapeutic area
- Leiomyoma